Daily Price Movement / General Discussion, page-29372

First 29372 Last

Share
Profile

Follow
AlphaX

8,124 Posts.

875

19/09/21

17:50

Post #: 56187705
Share

Originally posted by HLV693: ↑

Just watched the Q&A part of the retail investor day again. Interestingly, is the question "why aren't Zip announcing more merchant partnerships?"

Adam Ezra then goes on to say that Zip has "pilots in place with some of the largest retailers which of course we will only share with the market once they have progressed to a more mature state."

Peter then goes on to talk about how the ASX performs a materiality test for announcements and not all merchants are worthy due to Zip growing bigger.. the best part is when he says "although clearly there's some strategic and big size merchants that would truly be material and we are very very confident in the health of our pipeline and there are some very exciting announcements coming in the short and medium term."

So essentially they just continue to reiterate to the market that there are these significant "strategic" and "material" partnerships/updates coming soon. They hint that these updates are ASX worthy - meaning they are "big size" merchants/partners which will have a "material" impact for Zip.

As Zip is partnered with Microsoft AUS - could they be one of the "big retailer partnerships" and "pilots in place" currently happening in the US, as Microsoft were seeking to expand their BNPL services globally. Speculation only.

IMO I would not be surprised to see a huge partnership soon with potentially a banking/financial service. If you watch closely they touch on opportunities to be able to affiliate with banks to provide BNPL to their customers several times during the presentation. They express that there are significant opportunities available to them thanks to the Square/APT deal.

I'm impressed with their confidence moving forward and that they are consistently at work cutting deals. All will be revealed soon enough!

Expand

agree and it’s exciting but not to sound like a spoil sport

if you want a pump and dump, then announce a new onboarded vendor partnership

if you want real and permanent value, bring on a meaningful investor and tech partner.

Z1P Price at posting: $6.84 Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

PDN

Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

FRB

Firebird achieves preliminary approvals for its Jinshi plant design

There are more pages in this discussion • 17,190 more messages in this thread...

First 29372 Last

Add ZIP (ASX) to my watchlist

(20min delay)
Last $2.75		Change 0.000(0.00%)		Mkt cap ! $3.590B

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
3	11499	$2.88

Sellers (Offers)

Price($)	Vol.	No.
$2.61	532	1

View Market Depth

No.	Vol.	Price($)
3	11499	2.880
3	285	2.820
1	6003	2.810
2	3209	2.800
1	4482	2.760

Price($)	Vol.	No.
2.610	532	1
2.620	998	1
2.650	18	1
2.660	4291	8
2.690	47	1

Last trade - 10.02am 02/10/2024 (20 minute delay)

ZIP (ASX) Chart

Day chart unavailable

Daily Price Movement / General Discussion, page-29372

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Firebird achieves preliminary approvals for its Jinshi plant design

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Daily Price Movement / General Discussion, page-29372

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Firebird achieves preliminary approvals for its Jinshi plant design

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News